INTRODUCTION
============

The incidence of fungal infections in hospitals is increasing substantially in different parts of the world. This is due, among other factors, to the increase of immunocompromised patients undergoing invasive treatments and prolonged hospital stay[@B27]. *Candida* spp. is the most frequent genus of fungal infections, in the U.S. it is the fourth agent of bloodstream infections, which are considered severe and with attributed mortality rates of 30-60%[@B04] [@B08] [@B18]. In Brazil, the incidence of candidemia in teaching hospitals is of 2.49 cases per 1,000 admissions[@B14], which represents the values 6.6-12.5 times higher than those reported in some European countries[@B14]. *C. albicans* is still the most frequently isolated species of both superficial and invasive infections in Brazil as well as in the world[@B03] [@B09].

Despite the evidence for transmission of *Candida* spp. by direct or indirect contact and evidence of cross-infection by health care workers, little is known about the origin of clinical isolates of *C. albicans*. Information on molecular epidemiology has great relevance for the clinical management, treatment and epidemiology of recurrent infections, especially among critically ill patients[@B10] [@B11] [@B30]. This context led to the proposal of a variety of molecular typing techniques aiming at distinguishing isolates of *Candida* spp. from different sources. Among others, the best known are: multilocus sequence typing (MLST), pulsed-field gel electrophoresis (PFGE), duplex PCR, restriction fragment length polymorphisms (RFLP), randomly amplified polymorphic DNA (RAPD) and microsatellites[@B05] [@B13] [@B21] [@B26] [@B31] [@B34] [@B38].

The microsatellite analysis is a technique which has been recently used for genotyping *C. albicans* [@B01] [@B06] [@B07]. It is formed by short tandem repeats of two to six nucleotides known to be highly polymorphic, generating a characteristic profile of different alleles for a given *locus*. Due to its high discriminatory potential, this approach allows studies of nosocomial transmission routes[@B06] [@B32] [@B33]. Microsatellite has been used to investigate the molecular profile of *C. albicans* from healthy individuals[@B15], HIV sero-positive[@B26] and with recurrent vulvovaginal candidiasis[@B32].

Among the currently available to *C. albicans* genotyping techniques, RAPD is relatively cost-effective and it offers similar resolving power to electrophoretic karyotyping. These characteristics together with dendrograms of genetic relatedness among *C. albicans* isolates has significantly advanced lineage studies over progressive infective episodes or during asymptomatic carriage[@B16] [@B36]. In addition, RAPD has been used to investigate infections caused by identical or similar strains[@B35], emergence of resistance strains during antifungal therapy[@B20] [@B26], colonization patterns of yeast strains in different clinical situations, and microevolution of strains within a particular species[@B20].

Thus, the aim of this study was to determine the genetic relatedness of *C. albicans* from hospitalized patients by using the RAPD and microsatellites assays.

MATERIAL AND METHODS
====================

**Microorganisms:** A total of 39 strains of *C. albicans* isolated from different sources of patients hospitalized at University Hospital of Maringa in 2009, were used in this study. The yeasts were screened in chromogenic media CHROMagar^®^ *Candida* and identified by conventional phenotypic methods (germ tube, microculture in cornmeal agar supplemented with 1% Tween 80, auxanogram and zymogram test)[@B39].

Yeasts were taken from the following sources: urine 51.5% (N = 20), blood 20.5% (N = 8), catheter tip 15.5% (N = 6), orotracheal discharge 10% (N = 4) and peritoneal fluid 2.5% (N = 1). Regarding hospital sectors, 49% (N = 19) were isolated from adult Intensive Care Unit (ICU), 18% (N = 7) medical clinic, 13% (N = 5) pediatrics, 7.5% (N = 3) Neonatal Intensive Care Unit (NICU), 5% (N = 2) surgical clinic and 7.5% (N = 3) pediatric ICU.

**DNA Extraction:** The yeast strains were grown overnight at 25 °C using Sabouraud Dextrose Broth (SDB, Difco, USA) and genomic DNA extracted as described by CHONG *et al.* [@B12]. The concentration (260 nm) and purity (260/280) of the genomic DNA obtained were determined by optical density in a spectrophotometer, the visualization was made out in agarose gel at 0.7% with 1X TBE buffer (Tris-base 90 mmol l^--1^, Boric acid 90 mmol l^--1^, EDTA 2 mmol l^--1^ pH 8.0).

**Nested-PCR:** Identification of yeasts was confirmed by Nested-PCR which comprised two amplification stages, according to LUO & MITCHELL[@B23]. Briefly, primers that amplified Internal Transcribed Spacer (ITS) fragments of DNAr and identified the genus *Candida* were used in the first reaction. Amplification of species specific primers was used in the second reaction.

**RAPD (*Random Amplified Polymorphic DNA*):** RAPD was performed using the kit *Ready-To-Go* RAPD *Analysis Beads* ^®^ (Amersham Biosciences Corporation, Piscataway, NJ, USA) as described by the manufacturer. The RAPD reactions were performed by adding 30 ng of genomic DNA, one µmol l^--1^ oligonucleotide and water for a final volume of 25 µL to each tube containing *Ready-To-Go beads*. The oligonucleotides used were M2 (5′-CTTGATTGCC-3′)[@B25] and P4 (5′-AAGAGCCCGT-3′ - Analysis Kit Ready-To-Go/RAPD Beads). The reaction was conducted in a in a Eppendorf Mastercycler Gradient Thermocycler^®^ as follows: 95 °C for five min, followed by 45 cycles consisting of 95 °C for one min, 36 °C for one min and 72 °C for five min. Control tubes without template DNA were included in each run and reproducibility of the method was checked by repeating the amplification using different DNA extractions from two isolates and at least three different days.

The PCR products were electrophoresed in 2% agarose gel (w/v) in 1X TBE buffer at 150 volts for three hours. Amplicons in the gel were stained with ethidium bromide (0.5 mg mL^--1^) and visualized under UV transillumination (UVP Bioimaging Systems, Upland, CA^®^). The RAPD profiles were analyzed using Bionumerics^®^ software version 4.6 (Applied Maths^®^).

The similarity was verified by the coefficient (*S~AB~*) between each pair of standards for A and B isolates and calculated with the formula *S~AB~ = 2E / (2E + a + b)*, where *E* is the number of common bands in the patterns A and B, *a* is the number of bands with an *a* pattern and no *B* correlated patterns, and *b* is the number of bands with *B* pattern and no correlation in pattern A. From the similarity matrix, the units were grouped by UPGMA (Unweighted Pair-Group Method with Arithmetical Average). An *S~AB~* value of 1.00 indicates that the pattern of bands for line A is identical to B; values between 0.80 to 0.99 represent very similar clinical isolates but not identical, and may suggest microevolution of a single strain; *S~AB~* values less than 0.80 represent independent lines[@B12].

**Microsatellites:** Samples were genotyped using two microsatellite markers, CDC3 and HIS3, whose primer sequences were shown in [Table 1](#t01){ref-type="table"}, and all technical procedure was performed as described by BOTTEREL *et al.* [@B07]. The amplification products were analyzed by electrophoresis in polyacrylamide gel at 8% (w/v) in 1X TBE buffer for five hours at 140 volts. For the determination of the sizes of the fragments we used the molecular size marker 25 bp (Invitrogen^®^). After the run, the gel was stained with ethidium bromide (0.5 mg mL^--1^) and photodocumented under UV transillumination (UVP Bioimaging Systems, Upland, CA^®^). The size of the amplified fragments was determined by image analysis software LabImage 1D (Loccus Biotech^®^).

Table 1Primers used for genotyping of *C. albicans* isolates by Microsatellite and RAPD*Locus* (GenBank access number), chromosomePrimerNucleotide sequence (forward and reverse)Microsatellite*CDC3* (Z25869), chromosome 1CDC35′-CAGATGATTTTTTGTATGAGAAGAA-3′5′-CAGTCACAAGATTAAAATGTTCAAG-3′*HIS3* (AF006605), chromosome 2HIS35′-TGGCAAAAATGATATTCCAA-3′5′-TACACTATGCCCCAAACACA-3′RAPD-P45′-AAGAGCCCGT-3′-M25′-CTTGATTGCC-3′

The results were expressed according to the tested locus name and size of the two alleles observed in base pairs. The reproducibility of this step was ensured by the inclusion of analysis of a strain of *C. albicans* ATCC 38696 which provided repeatable and consistent results with those obtained by BOTTEREL *et al.* [@B07].

RESULTS
=======

**Analysis by Nested-PCR:** Amplifications with primers ITS1/ITS4 resulted in patterns of bands with 500 bp identifying *Candida* spp. The species-specific primers provided amplification of fragments with approximately 272 bp, thus confirming the classic identification that the isolated are indeed *C. albicans* species.

**RAPD profiles:** Analysis using primer M2 demonstrated the formation of 10 profiles with values of 0.84 ± 0.126 for *S~AB~* ([Fig. 1](#f01){ref-type="fig"}). Three groups (I, II and III) were formed with 67% similarity between them. Group I consisted of four subgroups (IA, IB, IC and ID), which clustered approximately 70% of the isolates with similarity of 80%. Primer P4 generated 11 different profiles, with a *S~AB~* value of 0.88 ± 0.08. There was the formation of only one cluster, containing 95% of the isolates with approximately 85% similarity ([Fig. 2](#f02){ref-type="fig"}).

Fig. 1Dendrogram generated by amplification of primer M2 and by UPGMA grouping, in which *S~AB~* was calculated by the coefficient of Dice for 39 *C. albicans* isolates. Vertical line divides dendrogram as from the 80% similarity level; the four sub-groups (IA, IB, IC and ID) gather almost 70% of samples. In the samples identification the equal number and different letter mean same patient. SC: Surgery clinic; aICU: adult ICU; pICU: pediatry ICU; nICU: neonatal ICU; MC: Medical clinic; Ped: Pediatrics.

Fig. 2Dendrogram generated from the amplification by primer P4 and by UPGMA grouping, in which *S~AB~* was calculated by the coefficient of Dice for 39 *C. albicans* isolates. Vertical line divides dendrogram as from 80% similarity level, in which Group I gathers 95% of samples. In the samples identification the equal number and different letter mean same patient. SC: Surgery clinic; aICU: adult ICU; pICU: pediatry ICU; nICU: neonatal ICU; MC: Medical clinic; Ped: Pediatrics.

**Microsatellites:** For all isolates tested we obtained products characteristic of microsatellite amplification. One or two PCR fragments by locus were produced for each isolate, since *C. albicans* is diploid, and each fragment was defined as an allele. The observed differences in size of alleles are attributed to the different numbers of repeats of microsatellites. The strains with two PCR products were typed as heterozygous, while those who had a single amplification product were considered homozygous.

The analysis of independent 39 isolates showed that all microsatellite loci were polymorphic, evidencing between six and seven alleles, and eight and nine different genotypes for the CDC3 and HIS3 primers respectively ([Table 2](#t02){ref-type="table"}). The discriminatory power (DP) was calculated for each marker according to the Simpson index:where *N* is the number of strains, *s* is the total number of different genotypes, and *nj* is the number of strains of genotype *j* [@B22]. The results showed that *CDC3* was the microsatellite with the highest DP value (0.85), while *HIS3* presented the lowest DP value (0.90). When the two markers are combined, the DP was 0.91. An index over or greater than 0.90 is desirable if the typing results are to be interpreted with confidence[@B22].

Table 2Origin of 39 *Candida albicans* isolates and their respective genotypes determined by microsatellite analysisSamplesOrigin of isolates*Primer CDC3Primer HIS3*NGenotypesH. U.SourceAllele 1 (bp)Allele 2 (bp)Allele 1 (bp)Allele 2 (bp)2ASCBlood1291251501942A2BaICUTOT12912515019407aICUCatheter tip1211171541541B3BpICUCatheter tip1291251501622C3ApICUBlood12912515016208aICUCatheter tip1251171621629D11nICUBlood12511716216232MCUrine12511716216233aICUUrine12511716216220PediatricsCatheter tip12511716216234aICUTOT12511716216221aICUUrine12511716216219aICUUrine12511716216210nICUBlood1251171621621BPediatricsCatheter tip1371211581626E23MCUrine13712115816230MCUrine13712115816214aICUUrine13712115816215aICUUrine1371211581621APediatricsBlood1371211581624AMCBlood1291211581584F4BMCUrine1291211581585BaICUCatheter tip1291211581585AaICUTOT12912115815809aICUBlood1171131501622G13aICUPeritoneal fluid11711315016231aICUUrine1211211541742H06nICUBlood12112115417422MCUrine1211171661662I12aICUTOT12111716616617aICUUrine1251251661661J16aICUUrine1251251621622K18aICUUrine12512516216225pICUUrine1291211501501L24MCUrine1291211621625M28aICUUrine12912116216229aICUUrine12912116216227SCUrine12912116216226aICUUrine129121162162[^1]

The 39 samples were recovered from 34 patients because in five of them the same species was isolated from two different sites. A comparison of the genetic profile by microsatellite and RAPD ([Table 3](#t03){ref-type="table"}) showed total identity between these pairs.

Table 3Similarity by Random Amplified Polymorphic DNA and genotype by Microsatellite of *Candida albicans* isolated in two sources from a same patientPatientSourceGenotypeRAPDCDC3 (bp)HIS3 (bp)S*~AB~* Primer M2S*~AB~* Primer P411B-- Catheter tip137:121158:1621.001.001A -- Blood137:121158:1621.001.0022B -- TOT129:125150:1941.001.002A -- Blood129:125150:1941.001.0033B -- Catheter tip129:125150:1621.001.003A -- Blood129:125150:1621.001.0044B -- Urine129:121158:1581.001.004A -- Blood129:121158:1581.001.0055A -- TOT129:121158:1581.001.005B -- Catheter tip129:121158:1581.001.00[^2]

DISCUSSION
==========

RAPD and microsatellite analysis were able to show similarity among *C. albicans* isolates recovered from a hospital. Microsatellite analysis supplied a good DP with markers used, it allowed formation of various genotypes grouping samples, confirming the similarity between them, which reinforces the interpretation of the data found in RAPD. Additionally, it was possible to prove the high similarity (100%) of the same yeast which was from colonization (urinary catheter, tracheal secretions) and later detected in blood cultures from the same patient.

The RAPD results showed *S~AB~* values of 0.84 ± 0.126 for the primer M2 and *S~AB~* 0.88 ± 0.08 for P4 ([Fig. 1](#f01){ref-type="fig"} and [2](#f02){ref-type="fig"}). It is important to highlight that the strains that are considered identical by a primer are not always necessarily also considered identical or belong to the same cluster when analyzed by another primer. This should be referred as a limitation of the technique, nevertheless according to CHONG *et al.* [@B12] the values found, in RAPD, indicate high similarity between the isolates.

In microsatellite analysis we were able to verify the presence of six different alleles with the primer CDC3 and seven alleles with primer HIS3, of which 113bp, 117bp, 125bp, 150bp, 154bp, 158bp and 162bp have already been recognized by other authors[@B01] [@B06] [@B07]. These primers amplify microsatellite regions highly polymorphic for *C. albicans*. Moreover, these regions are stable over generations and were chosen because they are located on different chromosomes, which increase the chances of finding polymorphisms[@B07]. The discriminatory power (DP) found using markers *CDC3* and *HIS3*, was 0.85 and 0.90 respectively. These results and especially the combined value of DP (0.91) are considered by several authors as reliable studies of molecular typing[@B07] [@B22]. The data presented in [Table 2](#t02){ref-type="table"} show the prevalence of genotypes (D, E, F, M), however, there is no relation with sites of isolation of yeasts. This type of observation has already been described in another study using the same genotyping technique[@B02] . Finally, by putting together epidemiological data ([Fig. 1](#f01){ref-type="fig"} and [2](#f02){ref-type="fig"}, [Table 2](#t02){ref-type="table"}), it is possible to observe the formation of groups with high similarity (90-100%). These are mostly from patients hospitalized in ICU where the evidence of common origin is of great importance. According to AL-KARAAWI *et al.* [@B02] , the clinical isolates of *C. albicans* tend to be genetically similar to each other if they were isolates from patients with a similar profile, as those interned in ICU. CHAVES *et al.* [@B10] recently showed that candidemic patients had highly related microsatellites genotype in colonizing and bloodstream isolates. However, it should be noted that the detection of yeasts highly similar in our study was not associated with hospital unit. The same profile was found in various hospital areas such as pediatric and internal medicine. These data reinforce that most *C. albicans* infections are from endogenous sources. They should also suggest that these strains may be circulating in the various units, but not characterizing the occurrence of outbreaks.

Although the infection of different patients from different sectors with yeasts of the same genetic profile insinuates cross-transmission[@B17] [@B19], high similarity among samples suggests an adaptation to the environmental conditions, thus characterizing microevolutions[@B28]. Five (14.70%) of all patients enrolled in this study are particularly interesting since *C. albicans* were isolated from different sites. In all cases the analysis confirmed that the clinical isolates were identical to each other ([Table 3](#t03){ref-type="table"}) indicating the migration of yeasts from colonization (urine catheters, tracheal secretion) into the blood, suggesting the source of systemic infection. This result indicates that each isolated pair has genotypic identity, suggesting clonal origin. This fact has been demonstrated by molecular typing, in several studies[@B10] [@B24] [@B29] [@B37] and helps confirm that previous colonization is an important predisposing factor for systemic infection.

Despite the small number of samples analyzed, this study contributes with the understanding on epidemiology of fungal infections in hospitals. The analyzed data allow us to conclude that both techniques generated reproducible profiles showing similarity among the isolates. These techniques are suitable for epidemiological molecular studies of *C. albicans* and can be applied in larger populations. The good performance of these techniques allows its use for genotyping of outbreaks of hospital origin or not, and characterization of isolates from different sites, including recurrent infections such as vulvovaginal candidiasis and investigations before and after treatments. Knowledge of the relationship of clinical isolates involved in infections is extremely important for the development and application of the correct therapeutic strategy and to better understand the epidemiology of these infections.

[^1]: SC: Surgery clinic; aICU (Intensive Care Unit): adult ICU; pICU: pediatric ICU; nICU: neonatal ICU; MC: medical clinic. N: number of genotype. H.U.: Hospital Unit; TOT: endotracheal aspirate.

[^2]: TOT: endotracheal aspirate.
